James Huang - Jun 30, 2025 SCHEDULE 13G/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)

Filing Manager
James Huang
Reporting Manager
James Huang
Security
CASI Pharmaceuticals, Inc. Ordinary Shares
Symbol
CASI
Shares outstanding
15.7M shares
Disclosed Ownership
2.16M shares
Ownership
13.8%
Form type
SCHEDULE 13G/A
Date filed
7/23/2025, 09:39 AM
Date of event
Jun 30, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Panacea Venture Healthcare Fund II, L.P. 13.2% 2.05M 0 2.05M By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner
Panacea Venture Healthcare Fund II GP Company, Ltd. 13.2% 2.05M 0 2.05M By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner
Panacea Innovation Limited 13.2% 2.05M 0 2.05M /s/ James Huang James Huang, Founding Managing Partner
James Huang 13.8% 2.16M 112K 2.05M /s/ James Huang James Huang